PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Mar-2023 Charles River Launches Helper Plasmid to Streamline Adeno-Associated Viral Vector Manufacturing Businesswire
09-Mar-2023 Bigfoot Biomedical Named to Fast Company’s “World’s Most Innovative Companies” List Businesswire
09-Mar-2023 Ribon Therapeutics Doses First Patient in Phase 1 Clinical Study with RBN-3143 in Patients with Moderate-to-Severe Atopic Dermatitis Businesswire
09-Mar-2023 Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S. Businesswire
09-Mar-2023 Vertex Announces FDA Clearance of Investigational New Drug Application for VX-264, a Novel Encapsulated Cell Therapy for the Treatment of Type 1 Diabetes Businesswire
09-Mar-2023 REVEAL GENOMICS®´ Breakthrough Technology Enters the Liquid Biopsy Field in Oncology Businesswire
09-Mar-2023 OmniAb to Report Fourth Quarter 2022 Financial Results on March 30 Businesswire
09-Mar-2023 The United States Micropump Market is projected to attain US$ 4.5 billion at a CAGR of 18.2% by 2033 | FMI Study MARKITWIRED
09-Mar-2023 Chromatography Instrumentation Market is expected to reach a valuation of USD 12.17 Billion by 2032 | FMI MARKITWIRED
09-Mar-2023 NeuPath CEO Letter to Shareholders Businesswire
09-Mar-2023 Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2022 Businesswire
09-Mar-2023 Areteia Therapeutics Announces Start of Phase III Clinical Trials of Oral Dexpramipexole in Eosinophilic Asthma Businesswire
09-Mar-2023 Intubation Tube Market in Japan is projected to register a CAGR of nearly 6.4% during 2022 to 2032 MARKITWIRED
09-Mar-2023 Pap Tests to Contribute the Most to HPV Testing and Pap Test Market throughout the Analysis Period | States Future Market Insights MARKITWIRED
09-Mar-2023 Coya Therapeutics to Host Conference Call Presenting Clinical Data of COYA 302 in Patients with Amyotrophic Lateral Sclerosis (ALS) on March 21, 2023, at 8:00am ET Businesswire
09-Mar-2023 Aldeyra Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights Businesswire
09-Mar-2023 ROME Therapeutics Appoints Keith Wilcoxen, Ph.D., as Executive Vice President, Early Development Businesswire
09-Mar-2023 Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit Businesswire
09-Mar-2023 Precision BioSciences Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update Businesswire
09-Mar-2023 Antev Receives US FDA Guidance on Teverelix® Phase 3 Trial Design for Treating Advanced Prostate Cancer Patients with Increased Cardiovascular Risk Antev Ltd